Machine Learning-Enhanced Mucosal Luminal Interface Metaproteomics Reveals Diagnostic Potential of Microbial Proteins in Pediatric Inflammatory Bowel Disease
Abstract: Background: Inflammatory Bowel Disease (IBD), a chronic gastrointestinal disorder with two main subtypes, Crohn's Disease (CD) and Ulcerative Colitis (UC), is associated with more aggressive phenotypes and greater diagnostic complexity in pediatric patients. Conventional diagnostic biomarkers, lack sufficient distinguishing power between IBD subtypes. This study aimed to investigate and compare proteomic and metaproteomic profiles of pediatric IBD (PIBD) patients and healthy controls to develop a diagnostic panel capable of accurately diagnose IBD and distinguish its subtypes. Methods: We performed an in-depth evaluation of mucosal luminal interface samples from PIBD patients and healthy individuals, separately analyzing both the human proteome and microbial metaproteome data. The study involved selecting appropriate protein sets, employing feature selection techniques and machine learning across three intestinal regions: the terminal ileum, ascending colon, and descending colon. Results: Notably, panels composed solely of microbial biomarkers outperformed both human-only and combined human-microbial panels, achieving highly accurate results. Furthermore, the ascending colon emerged as the optimal sampling site, a result that aligns with the rich microbial diversity revealed in its taxonomic profile. Conclusions: Using a machine learning-based strategy on combined proteomics and metaproteomics, this study uncovered disease-relevant signaling pathways and delivered taxonomic as well as functional insights into the microbial dysbiosis of PIBD. A diagnostic panel built around microbial proteins (particularly those originating from the ascending colon) emerges as a promising tool for more precise stratification of PIBD subtypes. Larger, prospective studies are now needed to validate these candidate biomarkers and translate them into clinically deployable diagnostic panels. Keywords: Metaproteome, Biomarker, Pediatric Inflammatory bowel disease, Machine learning, Mucosal luminal interface.